Merigan; Thomas C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merigan; Thomas C..The latest application filed is for "polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome".

Company Profile

0.9.4

Merigan; Thomas C. - Portola Valley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome App 20070141565 - Kozal; Michael J. ; et al.	2007-06-21
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 7,129,041 - Merigan , et al. October 31, 2	2006-10-31
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acouired immunodeficiency syndrome App 20060110726 - Kozal; Michael J. ; et al.	2006-05-25
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant RE38,352 - Kozal , et al. December 16, 2	2003-12-16
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome App 20030118986 - Merigan, Thomas C. ; et al.	2003-06-26
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 6,503,705 - Kozal , et al. January 7, 2	2003-01-07
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome App 20010018181 - Kozal, Michael J. ; et al.	2001-08-30
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 5,968,730 - Merigan , et al. October 19, 1	1999-10-19
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 5,856,086 - Kozal , et al. January 5, 1	1999-01-05
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 5,650,268 - Kozal , et al. July 22, 1	1997-07-22
Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome Grant 5,631,128 - Kozal , et al. May 20, 1	1997-05-20
Purified human cytomegalovirus protein Grant 4,743,562 - Rasmussen , et al. May 10, 1	1988-05-10
Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen Grant 4,140,761 - Gerin , et al. February 20, 1	1979-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.